Company news

CelLBxHealth plc news in 2021

CelLBxHealth plc's news releases, calls and decks from 2021, newest first.

View company

Parsortix in RNA analysis of CTCs as tool in NSCLC

December 1, 2021

Appointment of Chief Medical Officer

November 15, 2021

Participation at Jefferies healthcare conference

November 12, 2021

Parsortix system showcased at NCRI Festival

November 11, 2021

Change of Adviser

November 2, 2021

Parsortix demonstrates ability to isolate CTCs

September 27, 2021

Study shows use of Parsortix to assess PD-L1

September 22, 2021

Parsortix enables gene expression analysis in mPCa

September 20, 2021

Study highlights superior performance of Parsortix

August 9, 2021

Contract secured for bespoke assay development

July 28, 2021

Harvesting CTCs from brain metastasis patients

July 9, 2021

Result of AGM

June 30, 2021

Result of Accelerated Bookbuild

June 25, 2021

Accelerated bookbuild to raise up to £20m

June 24, 2021

Annual General Meeting update

June 18, 2021

Update on submission for FDA clearance

June 4, 2021

Potential to prevent breast cancer relapse

June 1, 2021

Parsortix demonstrates oesophageal cancer utility

May 20, 2021

Exercise of options and total voting rights

May 19, 2021

Parsortix study uncovers targets in TNBC patients

May 11, 2021

Ovarian cancer study patient enrolment completed

April 26, 2021

First large-scale pharma services contract secured

April 16, 2021

ANGLE's Parsortix system showcased at AACR 2021

April 12, 2021

Global launch of clinical services laboratories

March 30, 2021

Parsortix-harvested CTCs uncover novel biomarker

February 18, 2021

Parsortix: Dynamic assessment of patient response

February 8, 2021

Parsortix demonstrates high capture rate of CTCs

January 29, 2021

Research confirms high performance of Parsortix

January 20, 2021

Change of Auditor

January 12, 2021

Calls in 2021

Decks in 2021